Markos Kalligeros

机构：Beth Israel Deaconess Medical Center, Hadassah Medical Center · ORCID：0000-0002-5688-8702

发表论文 91 篇 · 总被引 1919 次 · h-index 21

代表论文

• Prevalence of Steatotic Liver Disease (MASLD, MetALD, and ALD) in the United States: NHANES 2017–2020 (2023 · Clinical Gastroenterology and Hepatology · 被引 232)
• Changes in the epidemiological trends of primary liver cancer in the Asia–Pacific region (2024 · Scientific Reports · 被引 40)
• Alcohol–Related Liver Disease, Followed by Metabolic Dysfunction–Associated Steatotic Liver Disease, Emerges as the Fastest‐Growing Aetiologies for Primary Liver Cancer in the United States (2025 · Alimentary Pharmacology & Therapeutics · 被引 13)
• Binge drinking, metabolic dysfunction, and the spectrum of steatotic liver disease in the USA: a cross-sectional and longitudinal analysis (2026 · ˜The œLancet. Gastroenterology & hepatology · 被引 11)
• Risk of infection in patients with hidradenitis suppurativa on biologics or other immunomodulators: a systematic review and meta‐analysis (2023 · International Journal of Dermatology · 被引 9)
• Risk of Infection in Patients With Inflammatory Bowel Disease Treated With Interleukin-Targeting Agents: A Systematic Review and Meta-Analysis (2024 · Inflammatory Bowel Diseases · 被引 8)